A nationally recognized expert in pediatric hematology and oncology has joined the Virginia Tech Carilion School of Medicine as chair of pediatrics.
Kimberly Dunsmore comes to the school from the University of Virginia Children’s Hospital where she was associate chair for clinical program development and was the Karen Jargowsky Endowed Chair for Pediatric Hematology/Oncology. She will also serve as chair of pediatrics for Carilion Clinic.
While with the University of Virginia Health System, Dunsmore was the primary investigator for the Children’s Oncology Group. She sat on the Acute Leukemia Committee and was the international primary investigator for the T-Cell ALL treatment protocol committee. She also served as director and primary investigator for the University of Virginia Health System’s Comprehensive Pediatric Sickle Cell Program and the Hemophilia Treatment Center.
Dunsmore’s research interests are in the areas of T-cell immune dysregulation and T-cell leukemia, clinical trials in pediatric oncology, innovative therapeutics for pediatric cancers, and pediatric hemophilia.
She has authored or co-authored numerous articles in peer-reviewed journals and book chapters and has been an invited presenter at a number of regional, national, and international conferences. Dunsmore has received awards for both teaching and clinical excellence and founded the first pediatric hospice program at the University of Virginia.
Dunsmore received her bachelor’s degree from the University of Tennessee and her medical degree from Emory University School of Medicine. She completed her residency in pediatrics and a fellowship in pediatric hematology/oncology at Duke University Medical Center.